ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002

In Brief: House Passes FY ’77 Money Bill, But Veto Seems Likely; NIH Relaxes Moonlighting Rule

August 20, 1976

NCI Program Review: Report calls For Two Types Of Centers: Comprehensive And All Others

October 18, 1996

House Panel Targets AWP For Medicare Drug Pricing.

October 5, 2001

Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS

March 31, 2000

NCI-Approved Clinical Trials Listed For June 2001

July 27, 2001